Governor Malloy has signed the following bills affecting bioscience in Connecticut:
This bill allows certain terminally ill patients to access medications and devices not yet approved for general use. The bill allows investigational drug manufacturers to provide eligible patients with investigational drugs.
The bill makes projects to develop bioscience businesses eligible for assistance from the Department of Economic and Community Development’s (DECD) Office of the Permit Ombudsman.
This bill allows Connecticut Innovations, Inc. (CI) to use its unrestricted funds and funds in the Connecticut Bioscience Innovation Fund (CBIF) to invest in private equity investment funds under certain conditions.
This bill directs the chairpersons of the Commission on Economic Competitiveness to appoint and convene a health data collaborative working group to examine and make recommendations.
This bill requires the Department of Economic and Community Development (DECD) to develop legislative recommendations regarding the exchange of unused research and development credits for state financial assistance.